Diego Miralles

Diego Miralles is currently Director at S.V.D.P.
Management, Inc. since 2025, Director at ArrePath, Inc., Director at Contineum Therapeutics, Inc. since 2025, Director at Rady Children's Institute for Genomic Medicine since 2008, Venture Partner at CHP Management, Inc., Adjunct Professor at the University of California San Diego, and President & Head-Research & Development at Artiva Biotherapeutics, Inc. starting in 2026.
Former roles include President, Chief Executive Officer & Director at Laronde, Inc. from 2020 to 2022; Chief Executive Officer & Director at Vividion Therapeutics, Inc. from 2017 to 2020; Director at NeuBase Therapeutics, Inc. from 2019 to 2021; Medical Director at Triangle Pharmaceuticals, Inc. from 1998 to 2000; Senior Director at Trimeris, Inc. from 2000 to 2005; Director at Neubase Therapeutics, Inc.; Director at CONNECT; Assistant Professor at Duke University Medical Center; Member-Management Board at Tibotec Virco Virology BV; President at Adaptive Therapeutics, Inc. from 2016 to 2017; and Advisor at Flagship Pioneering, LLC from 2022 to 2023.
Education includes a doctorate from Universidad de Buenos Aires conferred in 1986.